Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Marietta. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Marietta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up to 168 weeks, with a treatment period of up to 158 weeks including an open-label (OL) long-term extension (LTE) period of up to 104 weeks for eligible participants
Sponsor: Sanofi
Check if you qualify for this crohn's disease clinical trial in Marietta, GA
If you're searching for crohn's disease treatment options in Marietta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Marietta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.